Table 2.
MRONJ-Related Therapy | Months |
---|---|
Duration of therapy | |
-Zoledronate | 34.29 ± 33.42 |
-Alendronate | 79.42 ± 63.33 |
-Denosumab | 15 ± 7.94 |
Suspension of drug | |
-Zoledronate | 8.53 ± 20.21 |
-Alendronate | 13.15 ± 19.58 |
-Denosumab | 0.8 ± 1.1 |
MRONJ-Related Therapy | Months |
---|---|
Duration of therapy | |
-Zoledronate | 34.29 ± 33.42 |
-Alendronate | 79.42 ± 63.33 |
-Denosumab | 15 ± 7.94 |
Suspension of drug | |
-Zoledronate | 8.53 ± 20.21 |
-Alendronate | 13.15 ± 19.58 |
-Denosumab | 0.8 ± 1.1 |